Looking into the neurological diseases we could identify a tight connection between the kappa- and delta- type opioid receptors, while for cardiovascular diseases a network of the 5-hydroxytryptamine receptors is highly targeted by the same drug-food pairs. This evidence concerns the gene OPRD1 and nervous system disorder.